Centre for Health Economics

Activities

Activities per year 1992 2012 2013 2014 2015 2016 2017 2018 2023

• 364 Conference participation
• 201 Invited talk
• 168 Publication peer review
• 137 Seminar/workshop/course
• 478 More
  • 63 Oral presentation
  • 51 Media (Other online)
  • 30 Committee
  • 29 Conference
  • 26 Workshop
  • 23 Peer review of research grants
  • 21 Panel
  • 20 Seminar
  • 18 Working group
  • 16 Editorial board
  • 16 Public engagement and outreach (social community and cultural engagement)
  • 15 Board
  • 14 Media (Press)
  • 14 Lecture
  • 11 Collaboration
  • 10 Advisory Group
  • 9 Media (Radio)
  • 8 Types of External academic engagement - Research and Teaching at External Organisation
  • 8 Public lecture
  • 6 Journal or guest editorship
  • 6 Public engagement and outreach (general)
  • 6 Talk
  • 6 Webinar
  • 5 Academic
  • 5 CPD delivery
  • 5 PhD
  • 4 Types of Award - Appointment
  • 3 Consultancy (in kind)
  • 3 Journal
  • 3 Research Group
  • 2 Symposium
  • 2 Forum
  • 2 Association
  • 2 Peer Review College
  • 2 Society
  • 2 Media (TV)
  • 1 Festival
  • 1 Consultancy (paid)
  • 1 Other
  • 1 Council
  • 1 Learned society
  • 1 Network
  • 1 Professional body
  • 1 Appointment
  • 1 Types of Award - Prize (including medals and awards)
  • 1 Mentoring
  • 1 Commercial
  • 1 Government

Activities per year

Search results

• Pushing the Frontiers of Comprehensive Health Technology Assessment: Assessing the Tradeoff between Efficiency and Equity

  Ana Isabel Duarte (Keynote/plenary speaker), Stefan Sauer (Keynote/plenary speaker), Michal Staňák (Keynote/plenary speaker) & Uwe Siebert (Chair)

  23 May 2023

  Activity: Talk or presentation › Invited talk

• Collaborative Care for people with cancer

  Ana Isabel Duarte (Invited speaker)

  18 May 2023

  Activity: Talk or presentation › Invited talk

• Health Equity in HEOR: Past, Present, & Future Research Implications

  Shainur Premji (Invited speaker)

  31 Mar 2023

  Activity: Talk or presentation › Invited talk

• Value of Information (VoI) Analysis for estimating the benefits of undertaking additional Studies Within A Trial (SWATs) on pens as a retention strategy

  Athanasios Gkekas (Chair)

  15 Dec 2022

  Activity: Talk or presentation › Invited talk

• Emergency readmissions: is 30-day the optimal time interval to capture hospital quality of care?

  Adriana Castelli (Chair)

  4 Nov 2022

  Activity: Talk or presentation › Invited talk

• Learning Optimal Treatment Rules Using Machine Learning and Decision Modelling

  David Glynn (Invited speaker) & Noemi Kreif (Invited speaker)

  13 Oct 2022

  Activity: Talk or presentation › Invited talk

• A supply side cost-effectiveness threshold for Indonesia

  Jessica Marie Ochalek (Invited speaker) & Noemi Kreif (Invited speaker)

  4 Oct 2022

  Activity: Talk or presentation › Invited talk

• Target trial emulation methods for the analysis of RWD to support HTA decisions

  Andrea Manca (Chair)

  27 Sept 2022

  Activity: Talk or presentation › Invited talk

• An economic evaluation alongside a pilot study of early Tissue Doppler Evaluation of Diastolic Dysfunction in Emergency Department Non-ST Elevation Acute Coronary Syndromes

  Vijay Singh Gc (Invited speaker)

  11 Aug 2022

  Activity: Talk or presentation › Invited talk

• Health economics in social care research

  Helen Louise Ann Weatherly (Invited speaker)

  28 Jun 2022

  Activity: Talk or presentation › Invited talk

• Measuring health system productivity: the case of the English National Health Service

  Adriana Castelli (Chair)

  14 Jun 2022

  Activity: Talk or presentation › Invited talk

• Using longitudinal individual patient-level data from observational registry studies to inform healthcare decisions: the case of myelodisplastic syndrome

  Andrea Manca (Chair)

  18 May 2022

  Activity: Talk or presentation › Invited talk

• Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers

  Simon Mark Walker (Invited speaker)

  16 Nov 2021

  Activity: Talk or presentation › Invited talk

• Why and how to use cost-effectiveness analysis in healthcare?

  Rita Faria (Speaker)

  2 Nov 2021

  Activity: Talk or presentation › Invited talk

• Program Evaluation of Population- and System-Level Policies: Evidence for Decision Making

  Simon Mark Walker (Invited speaker)

  28 Oct 2021

  Activity: Talk or presentation › Invited talk

• Cost-effectiveness analysis of alternative cascade testing protocols for familial hypercholesterolaemia

  Rita Faria (Invited speaker)

  4 Oct 2021

  Activity: Talk or presentation › Invited talk

• Jointly modelling economics and epidemiology to support public policy decisions for the COVID-19 response: a review of UK studies

  Simon Mark Walker (Invited speaker)

  24 Sept 2021

  Activity: Talk or presentation › Invited talk

• Economic evaluation of health technologies

  Rita Faria (Invited speaker)

  21 Jul 2021

  Activity: Talk or presentation › Invited talk

• U.S. Health Care Expenditures: Addressing the Opportunity Cost for Population Health--A Workshop

  Simon Mark Walker (Invited speaker)

  16 Mar 2021

  Activity: Talk or presentation › Invited talk

• H2020 HTx and MDS-RIGHT collaboration: HTA methods development and clinical questions

  Theo de Witte (Chair) & Andrea Manca (Invited speaker)

  9 Mar 2021

  Activity: Talk or presentation › Invited talk

• Constructing relative effect priors for research prioritisation and trial design: a meta-epidemiological analysis

  David Glynn (Invited speaker)

  23 Feb 2021

  Activity: Talk or presentation › Invited talk

• Pharmacoeconomics: an Appropriate Tool for Policy Makers Around the World. Sharing International Experience

  Rita Faria (Invited speaker) & Dalia Dawoud (Invited speaker)

  5 Dec 2020

  Activity: Talk or presentation › Invited talk

• Session 3: Work Package 1 - Lessons from Each Dataset

  Fan Yang (Chair)

  10 Nov 2020

  Activity: Talk or presentation › Invited talk

• Session 1: Work Package 1 - Data Sources

  Fan Yang (Speaker) & Jessica Marie Ochalek (Speaker)

  10 Nov 2020

  Activity: Talk or presentation › Invited talk

• Session 2: Work Package 1 - Preliminary Findings

  Fan Yang (Chair)

  10 Nov 2020

  Activity: Talk or presentation › Invited talk

• Informing a Cost‑Effectiveness Threshold for Health Technology Assessment in China: A Marginal Productivity Approach

  Jessica Marie Ochalek (Invited speaker)

  1 Nov 2020

  Activity: Talk or presentation › Invited talk

• HTA and reimbursement of Gene Therapies - Practical lessons from cell therapy appraisals

  Ana Isabel Duarte (Invited speaker)

  26 Oct 2020

  Activity: Talk or presentation › Invited talk

• Practical methods to support research prioritisation decisions: rapid assessment of the need for evidence

  David Glynn (Invited speaker)

  6 Dec 2019

  Activity: Talk or presentation › Invited talk

• Health Opportunity Costs and Cost-effectiveness Thresholds

  Jessica Marie Ochalek (Invited speaker)

  27 Oct 2019

  Activity: Talk or presentation › Invited talk

• Health Opportunity Costs and Cost-effectiveness Thresholds

  Jessica Marie Ochalek (Invited speaker)

  23 Oct 2019

  Activity: Talk or presentation › Invited talk

• Evidence for the impact of interventions for, and medicines reconciliation in, problematic polypharmacy: a rapid review of systematic reviews and scoping searches

  Rita Faria (Invited speaker)

  19 Sep 2019

  Activity: Talk or presentation › Invited talk

• Challenges in the economic evaluation of ATMPs

  Ana Isabel Duarte (Invited speaker)

  24 Jun 2019

  Activity: Talk or presentation › Invited talk

• A bridge over the troubled waters: the value of registry data for HTA decisions

  David Bowen (Chair), Pierre Fenaux (Chair) & Andrea Manca (Speaker)

  31 Mar 2019

  Activity: Talk or presentation › Invited talk

• Determining how policies change health inequality to inform funding decisions

  Susan Griffin (Invited speaker)

  22 Mar 2019

  Activity: Talk or presentation › Invited talk

• Thanzi la Onse (Health of all) - Health Benefits Package Design in LMIC

  Matthias Arnold (Chair)

  29 Nov 2018

  Activity: Talk or presentation › Invited talk

• Accounting for health opportunity costs in health benefits package design

  Jessica Marie Ochalek (Invited speaker)

  30 Oct 2018

  Activity: Talk or presentation › Invited talk

• Seminar: Generic economic evaluation model for follicular lymphoma: predicting treatment cost, life expectancy and quality-adjusted-life-year for different scenarios using UK population based observational data

  Han I Wang (Speaker)

  18 Oct 2018

  Activity: Talk or presentation › Invited talk

• The Economics of Mental Health and Mental Health Care

  Rowena Jacobs (Invited speaker)

  17 Sept 2018 → 19 Sept 2018

  Activity: Talk or presentation › Invited talk

• Accounting for Health Opportunity Costs Benefits Package Design

  Jessica Marie Ochalek (Invited speaker)

  19 Jul 2018

  Activity: Talk or presentation › Invited talk

• Experiences of structured elicitation for cost-effectiveness analyses

  Marta O Soares (Invited speaker)

  29 Jun 2018

  Activity: Talk or presentation › Invited talk

  File

• The organisation and funding of mental health services

  Rowena Jacobs (Keynote/plenary speaker)

  28 Jun 2018 → 30 Jun 2018

  Activity: Talk or presentation › Invited talk

• The organisation and funding of mental health services

  Rowena Jacobs (Keynote/plenary speaker)

  25 Jun 2018 → 26 Jun 2018

  Activity: Talk or presentation › Invited talk

• Judging cost effectiveness: Decision rules, value judgments and thresholds

  Jessica Marie Ochalek (Invited speaker)

  15 May 2018

  Activity: Talk or presentation › Invited talk

• Cost-effectiveness of mpMRI, TRUS-biopsy and TPM-biopsy to diagnose clinically significant prostate cancer

  Rita Faria (Invited speaker)

  18 Apr 2018

  Activity: Talk or presentation › Invited talk

• Demonstrating the value of diagnostics to health systems: lessons learnt from a cost-effectiveness evaluation in prostate cancer (PROMIS study)

  Marta O Soares (Speaker)

  16 Mar 2018

  Activity: Talk or presentation › Invited talk

• Incorporating health inequality concerns into cost-effectiveness analysis

  James Love-Koh (Invited speaker)

  21 Sept 2017

  Activity: Talk or presentation › Invited talk

• On health economic evaluation and precision medicine

  Andrea Manca (Invited speaker)

  Sept 2017

  Activity: Talk or presentation › Invited talk

• Economic Evaluation

  Jessica Marie Ochalek (Speaker)

  21 Jul 2017

  Activity: Talk or presentation › Invited talk

• Quality in primary care: is it possible to identify peer effects among English GP practices? (work with Hugh Gravelle and Nigel Rice),

  Rita Santos (Invited speaker)

  22 May 2017

  Activity: Talk or presentation › Invited talk

• Economic evaluation for decision-making and the value of access to individual patient data

  Andrea Manca (Invited speaker)

  13 Feb 2017

  Activity: Talk or presentation › Invited talk